Ionis Pharmaceuticals (IONS) Operating Margin Growth (5y) (2014 - 2026)

Ionis Pharmaceuticals (IONS) Operating Margin Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn -
2 Nanobiotix 1,908.96 Bn 1,908.90 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 474.03 Bn 469.24 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.13 Bn 114.88 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.09 Bn 61.34 Bn 3.31 Bn
7 Belite Bio 62.34 Bn 62.34 Bn -
8 Argenx Se 55.96 Bn 50.77 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.53 Bn 34.52 Bn 959.66 Mn
10 Ionis Pharmaceuticals 9.24 Bn 7.32 Bn 243.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3,469.00
Dec 31, 2025 -5,046.00
Sep 30, 2025 -7,939.00
Jun 30, 2025 738,891.00
Mar 31, 2025 -6,575.00
Dec 31, 2024 -62,814.00
Sep 30, 2024 -12,118.00
Jun 30, 2024 28,444.00
Mar 31, 2024 -20,614.00
Dec 31, 2023 -6,350.00
Sep 30, 2023 8,637.00
Jun 30, 2023 -517.00
Mar 31, 2023 -7,645.00
Dec 31, 2022 -12,318.00
Sep 30, 2022 -4,659.00
Jun 30, 2022 -6,966.00
Mar 31, 2022 -5,735.00
Dec 31, 2021 2,447.00
Sep 30, 2021 -7,902.00
Jun 30, 2021 6,916.00